These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31207934)

  • 1. A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus.
    Bernelin-Cottet C; Urien C; Stubsrud E; Jakob V; Bouguyon E; Bordet E; Barc C; Boulesteix O; Contreras V; Barnier-Quer C; Collin N; Trus I; Nauwynck H; Bertho N; Schwartz-Cornil I
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31207934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection.
    Bernelin-Cottet C; Urien C; Fretaud M; Langevin C; Trus I; Jouneau L; Blanc F; Leplat JJ; Barc C; Boulesteix O; Riou M; Dysart M; Mahé S; Studsrub E; Nauwynck H; Bertho N; Bourry O; Schwartz-Cornil I
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infection.
    Sirisereewan C; Nedumpun T; Kesdangsakonwut S; Woonwong Y; Kedkovid R; Arunorat J; Thanawongnuwech R; Suradhat S
    Vet Immunol Immunopathol; 2017 Jan; 183():7-15. PubMed ID: 28063479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses.
    Suradhat S; Wongyanin P; Sirisereewan C; Nedumpun T; Lumyai M; Triyarach S; Chaturavittawong D; Paphavasit T; Panyatong R; Thanawongnuwech R
    Vaccine; 2016 Jan; 34(5):609-615. PubMed ID: 26724543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction.
    Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
    Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine GPX1 enhances GP5-based DNA vaccination against porcine reproductive and respiratory syndrome virus.
    Du L; Li B; Pang F; Yu Z; Xu X; Fan B; Tan Y; He K; Huang K
    Vet Immunol Immunopathol; 2017 Jan; 183():31-39. PubMed ID: 28063474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
    Li X; Galliher-Beckley A; Huang H; Sun X; Shi J
    Vaccine; 2013 Sep; 31(41):4508-15. PubMed ID: 23933333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.
    Pujhari S; Baig TT; Hansra S; Zakhartchouk AN
    Virus Res; 2013 May; 173(2):321-6. PubMed ID: 23353778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.
    Sun H; Workman A; Osorio FA; Steffen D; Vu HLX
    Vaccine; 2018 Jan; 36(1):66-73. PubMed ID: 29174314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
    Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
    J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells.
    Bassaganya-Riera J; Thacker BJ; Yu S; Strait E; Wannemuehler MJ; Thacker EL
    Viral Immunol; 2004; 17(1):25-37. PubMed ID: 15018660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
    Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
    Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
    Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
    Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
    Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
    Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.